부산대학교 도서관

Long-term survivors of metastatic TC appear to have an increased risk for CVD that is accompanied by an unfavorable CRF profile and signs of persisting endothelial damage. When compared with the threat for secondary malignancies after chemotherapy for TC, the increased risk for CVD may perhaps represent even a bigger problem. Unraveling of the pathogenesis of CVD after chemotherapy for TC cancer is of great importance and is the focus of several cross-sectional and prospective studies in TC patients currently underway at our institution. These investigations will provide opportunities for tailoring potential toxic treatment and guiding primary and secondary prevention strategies for serious side effects of chemotherapy treatment. [ABSTRACT FROM AUTHOR]